- Design
- Retrospective single-institution cohort
- Population
- 789 patients with non-metastatic head and neck cancer after definitive (chemo)radiotherapy
- Primary outcome
- Opioid use 3 months after radiotherapy
- Effect
- 70.0% at 3 months, 47.3% at 6 months; prior use aOR 2.57 (1.82-3.63)
A single-institution cohort (JAMA Otolaryngology-Head & Neck Surgery, 1 October 2026) followed 789 patients with non-metastatic head and neck cancer treated with definitive radiotherapy or chemoradiotherapy between 2011 and 2023.
Almost all (95%) received prescription opioids between diagnosis and six months after treatment. At three months after radiotherapy 70% were still taking them, and at six months 47%. Ongoing use at three months was associated with prior opioid use (adjusted OR 2.57), former smoking (1.55) and palliative care referral (3.90). Among the 296 who were opioid-naive before treatment, 58% were still taking opioids at three months and 38% at six.
Mucositis pain is real and opioids are often needed, but these figures suggest that many patients never come off them. The findings point to building an exit plan into the start of treatment: agreed tapering after mucositis heals, review at each follow-up, and adjuvant approaches for neuropathic pain. Single-centre data cannot show which strategies work.
- Agree an opioid tapering plan at the start of radiotherapy, not after it
- Review opioid need at every post-treatment visit
- Consider extra support for patients already on opioids before treatment, former smokers and those under palliative care
- Use adjuvants and mucositis care to reduce opioid need where appropriate
- Name who owns the prescription after treatment ends - oncology, ENT or primary care
Why it matters
Opioids started for mucositis are often never stopped, and no one owns the prescription after treatment.
Don't overread it
Prescription data show opioids were taken, not whether use was inappropriate or harmful.
The statistics, in plain English
Adjusted odds ratios above 1 mean higher odds of still taking opioids: those on opioids before treatment had about 2.6 times the odds. This is one US centre, and prescribing practice varies widely between countries.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for ent & head and neck surgery, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free